VRCA compared with ANIK: revenue, margins and what each company keeps, and the suppliers and customers both name

VRCAVerrica Pharmaceuticals Inc.

Mkt capRevenueRevenue

ANIKAnika Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

VRCAVerrica Pharmaceuticals Inc.

ANIKAnika Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VRCA 1

—Lytix BioPharma ASunlistedsupplier

Shared 0

No shared counterparties.

Only ANIK 1

JNJJohnson & Johnson MedTechcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

VRCAVerrica Pharmaceuticals Inc.

3.35▲+8.33%· post 3.35

Mkt cap$54.8MRevenue$6MQ2 FY26Revenue$36MFY25

ANIKAnika Therapeutics, Inc.

14.29▼−26.05%· post 14.29

ClosedNov 6 '26

Mkt cap$194.9MRevenue$31MQ3 FY26Revenue$113MFY25

Compare

ClosedNov 6 '26

VRCAVerrica Pharmaceuticals Inc.

ANIKAnika Therapeutics, Inc.

3.35▲+8.33%post 3.35

Price

14.29▼−26.05%post 14.29

$54.8M

Mkt cap

$194.9M

Q2 FY26$6M

Revenue

$31MQ3 FY26

FY25$36M

Revenue

$113MFY25

VRCA3.35▲+8.33%vsANIK14.29▼−26.05%ClosedNov 6 '26